Yearly Archives: 2016
News
Optum & PAREXEL to Accelerate Drug Development, Reimbursement & Market Access with EHR-Fueled
Collaboration will focus on advancing drug development by combining clinical research and real-world evidenceOptum and PAREXEL International (NASDAQ:PRXL) formed a strategic alliance to reduce...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read